metaverse medical affairs pharmaceutical industry virtual reality biotech

Virtual Reality and Medical Affairs in the Metaverse

by MSL Talk: Tom Caravela, Bruno Larvol
· The Carolan Group

Dec 6^th 2022
35 mins
E132

Share This Article

Summary

In this episode, Bruno Larvol joins the discussion to explore the metaverse and its potential impact on medical affairs. The conversation delves into the significance and future applications of the metaverse for Medical Science Liaisons (MSLs) and medical affairs departments, highlighting both opportunities and challenges of its integration. The episode examines the growing interest of the pharmaceutical and biotech industries in the metaverse, including its social implications. Concepts such as Ready Player 1, digital museums, and NFTs are discussed to illustrate the metaverse's potential. Bruno Larvol concludes with insights on the evolving landscape, followed by closing remarks and sponsor acknowledgments.

My guest today is Bruno Larvol, CEO and Founder of Larvol, we discuss Virtual Reality and Medical Affairs in the Metaverse

This episode is sponsored by Larvol, established in 2004, LARVOL combines the best of artificial and human intelligence to deliver expertly curated and personalized data solutions to medical affairs, competitive intelligence, commercial, and R&D teams within the pharmaceutical and biotech industry.

For more details, please visit www.larvol.com
Bruno discusses….

👉 What is the Metaverse and how does one access it
👉 How does Medical Affairs fit into the Metaverse and virtual reality
👉 What do pharma and biotech companies need to be doing with VR
👉 Examples of what companies and MSLs are doing with VR and the metaverse
👉 What other ways can companies benefit from the metaverse